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 Skeletal muscle has an outstanding regenerative capacity when damaged muscle 
mass is less than 20%. The volumetric muscle loss (VML) injury, muscle loss beyond self-
repair capacity, results in functional and morphological disability. This study investigated the 
effect of myofibers injection into a decellurized extracellular matrix (ECM) with resistance 
training on skeletal muscle growth following a VML injury. Male fisher 344 and 2 month old 
F344-Tg (UBC-EGFP) rats, as myofiber donors, were used in this study. Approximately 20% 
of the mass of the lateral gastrocnemius (LGAS) was excised, which was replaced by ECM in 
same dimensions. 30 myofibers were injected into the injury site in 7 days of post injury, 
Ladder climbing began at 10 days post defect surgery, and rats were subjected to climb a 
ladder every third day with weight for 6 weeks. Following 56 days of recovery, specific 
tension of FIB+EXE (105.77±3.63N/cm2) group was significantly higher than ECM 
(82.8±3.42N/cm2) group. EXE (5122±92μm
2
) group increased cross sectional area of intact 











20μm in the entire area showed a significant difference only in EXE group (46±4.2) 
compared to ECM group (35±3.89). EXE group (34±3.2) significantly increased the number 
of blood vessel compared to ECM group (22±3.3). A significant difference in connective 
tissue area in middle region of the ECM was quantified between EXE (45±1.6%) and ECM 
(69±1.9%) groups. Moreover, small muscle fiber area within ECM was significantly higher in 
EXE group (1.39±30.15 μm
2
) than ECM and FIB groups (0.67±0.15μm
2
). The data suggest 
that ECM transplantation with resistance training can repair a volumetric muscle loss injury 
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Skeletal muscles, a bundle of multinucleated and contractile fibers plays a key role in 
locomotion and structural support (Huard, Li et al. 2002, Juhas and Bursac 2013). Skeletal 
muscle shows a distinct self-repair capacity in most general injuries. Volumetric muscle loss 
(VML), however, becomes irreversible because large volume of fibrotic tissues occupies the 
place originally filled with myofibers. VML resulting in not only loss of muscle mass, but 
also damage to nerves, blood vessels, and extracellular matrix ECM causes functional deficits, 
cosmetic flaws, and a permanent handicap (Grogan, Hsu et al. 2011). Surgical free muscle 
transplantation is a common current treatment of VML, but complete functional and 
morphological repair remains still a big challenge.   
 The ECM, a three-dimensional structure that consists of glycoproteins, heparin 
sulfate proteoglycans, glycosamnoglycans, and type IV collagen, plays a critical role in 
functional and structural support of skeletal muscles (Clark, McElhinny et al. 2002). The 
ECM also serves as a storage of growth factors, and the ECM binds to and releases growth 
factors as well (Schultz and Wysocki 2009). The ECM stores growth factors including 
fibroblast growth factor (FGF), transforming growth factor-β (TGF-β), hepatocyte growth 
factor (HGF), and vascular endothelial growth factor (VEGF). Bidirectional interactions 
between ECM and these growth factors affect wound healing processes. Additionally, 
released chemokines from degrading ECM following skeletal muscle damage attract 
progenitor cells and stem cells (Beattie, Gilbert et al. 2008, Mauney, Olsen et al. 2010). 
Because of those roles of ECM, acellular ECM and biological scaffolds composed with ECM 
component proteins have been used to repair tissues such as cardiac muscles, skeletal muscle, 




Especially, acellular ECM scaffolds treated with progenitor cells have been extensively 
researched in VML injuries (Borschel, Dennis et al. 2004, Kochupura, Azeloglu et al. 2005, 
Merritt, Cannon et al. 2010). The implantation of a homologous acellular ECM seeded with 
MSC improved functional recovery after 42 days (Merritt, Cannon et al. 2010). The 
implantation of acellular ECM with myoblasts repairs abdominal wall defects (Coppi, Bellini 
et al. 2006), while only homologous acelluar ECM implantation results in a large volume of 
fibrous scar tissues (Conconi, De Coppi et al. 2005).  
Satellite cells (SCs), adult stem cells, are primary sources for skeletal muscle 
regeneration. SCs locating between basal lamina and sarcolemma (Mauro 1961) are 
mitotically quiescent. Quiescent SCs are characterized by Pax7, paired box7, which plays a 
key role in SC development and lineage determination. (Allen, Sheehan et al. 1995). Upon 
exposure to a damage environment, activated SCs start proliferating, they are referred to 
myoblasts. When SCs enter the differentiation phase, Myogenin and Myf 6 are highly 
expressed (Grounds, Garrett et al. 1992, Cornelison, Olwin et al. 2000). Myogenin is 
essential for the fusion of myoblasts either themselves or with existing myofibers. These 
small myofibers become mature which increase size and express contractile protein such as 
actin and myosin. Donor cells derived regenerating myofibers are investigated by donor gene 
expression in host cells Donor SCs not only fuse with themselves or host myofibers, but also 
exist as SCs within regenerating myofibers through self-renewal (Collins, Olsen et al. 2005, 
Sacco, Doyonnas et al. 2008). Even though SCs are primary sources contributing skeletal 
muscle regeneration, enzymatically dissociated and transplanted SCs result in incomplete 
muscle regeneration due to limited migration, donor-host histocompatibility and early death 




way to deliver SCs to a damaged muscle. SC delivery though individual single fiber 
transplantation would keep SC stemness because SCs are influenced by the original 
environment which could increase survival ratio of donor SCs. A single donor myofiber 
promotes muscle hypertrophy as well as an increase in CSA (Boldrin and Morgan 2013). 
Transplantation of a single myofiber containing only 7 SCs generates more than 100 new 
fibers containing 25,000-30,000 myonuclei (Collins, Olsen et al. 2005). Single fiber 
transplantation also resulted in hypertrophy and high force production. Moreover, donor fiber 
derived SCs in young age remains in a host muscle permanently which prevents age-related 
mass reduction (Hall, Banks et al. 2010). A previous study in our lab, transplanting 50 
myofibers into pre-embedded ECM results in an increase in the number of regenerating fiber 
and a decrease in decullularized area in a VML rat.  
Resistance training (RT) influences the functional properties in skeletal muscle by 
modifying fiber structure, mass, metabolism and promoting the release of growth factors. RT 
potentially induces large muscle mass and high contractile force. Moreover, both resistance 
and endurance training triggers angiogenesis and vascularization (Green, Goreham et al. 1999, 
Laughlin and Roseguini 2008).  
The vascularization is a particular concern in repairing or regenerating tissues in 
order to attract residence and circulating cells and provide nutrients and oxygen (Teixeira, 
Zamuner et al. 2003, Li, Zhu et al. 2007). New myofiber formation should synchronize with 
vascularization and innervation due to the role of blood vessels and nerves in skeletal muscle. 
SK-34 muscle derived stem cells triggered regeneration of myofibers, blood vessels, and 
nerves that were related to functional properties and mass recovery (Tamaki, Uchiyama et al. 




maintenance. Denervated skeletal muscle continues the path of degeneration due to the 
failure of neuromuscular junctions which results in atrophy and tissue necrosis (Järvinen, 
Järvinen et al. 2005). Since denervation results in adverse effects on the muscle, it is essential 
that regenerating myofibers following VML should accompany with innervation. The role of 
neurotrophic factors, nerve growth factor (NGF), neurotrophin-3(NT-3), and brain-derived 
neurotrophic factor (BDNF) in skeletal muscle regeneration has been researched. NGF is an 
important factor for the survival and growth of neuron. Phenotypic characterization of NGF 
knockout mice increase in cell death and muscle dystrophy (Ruberti, Capsoni et al. 2000). 
Muscle-derived stem cells treated with NGF enhances the engraftment efficiency (Yu, Dillon 
et al. 1999, Lavasani, Lu et al. 2006).  
Therefore, the purpose of this study was to determine the effect of regeneration of 














Skeletal Muscle Regeneration Overview 
 Skeletal muscle consists of a bundle of multinucleated and contractile fibers plays a 
key role in locomotion and structural support (Huard, Li et al. 2002, Juhas and Bursac 2013). 
An interaction between neuronal and vascular properties and extracellular matrix is closely 
related to muscle contractile properties (Huard, Li et al. 2002, Järvinen, Järvinen et al. 2005). 
The regenerative capacity of skeletal muscle has been widely studied. Even though the 
recovery time and the level of functional and morphological recovery depend on the type 
and severity of injury, skeletal muscle has an outstanding regenerative (Huard, Li et al. 
2002.) The process of self-regeneration in skeletal muscle can be generally divided into 
three distinct phases: destruction; repair; and remodeling (Järvinen, Järvinen et al. 2005). 
The destruction phase 
Skeletal muscle injury causes the rupture of plasma membranes with a calcium influx 
which activates calcium dependent proteases (Hurme, Kalimo et al. 1991). It leads to 
disintegration of myofibers and necrosis of the damaged muscle tissues. The damaged 
skeletal muscle forms a band which prevents the propagation of necrosis toward intact 
myofibers and repairs the plasma membrane associated damaged area (Järvinen, Järvinen et 
al. 2005). Neutrophils, the most plentiful type of white blood cells, are recruited initially to 
the defect area by chemokines including IL-8(CXCL8), MIP-2 (CXCL2) and KC (CSCL1) 
(Belperio, Keane et al. 2002). The phagocytic neutrophils clear up the debris by proteolytic 
and oxidative modification (Tidball and Villalta 2010). Activated fibroblasts and 
macrophages within the injury release chemokines which induce an influx of circulating 




cytokines such as IFN-gamma, TNF-alpha and LPS (Charge and Rudnicki 2004, Tidball 
2005, Juhas and Bursac 2013) follow neutrophils, and migrate to the damaged area through 
a blood stream to remove debris (Hurme, Kalimo et al. 1991, Cannon and Pierre 1998). 
Once inflammation has been mitigated, anti-inflammatory macrophages (M2 macrophages) 
activated by anti-inflammatory cytokines such as interlukine-4, 10 and 13 (Sica and 
Mantovani 2012) replace M1 macrophages (Arnold, Henry et al. 2007, Chazaud, Brigitte et 
al. 2009, Rigamonti, Zordan et al. 2014). M2 macrophages attenuate inflammation and 
tissue degradation by switching the initial injury environment toward a regenerative 
condition. Inflammatory cells play a role in muscle regeneration as clearing up debris and 
attracting myogenic precursor cells. 
Repair phase 
 The regeneration of myofibers and the formation of scar tissues are the distinct 
feature in the repair phase. The repair phase begins with the degeneration phase by the effect 
of M2 macrophages which activate SCs. Activated SCs proliferate and migrate to the site of 
injury (Juhas and Bursac 2013). Activated SCs expressing MyoD are characterized by the 
up-reulation of DNA synthesis and nuclear enlargement (Carlson and Faulkner 1982). Once 
myoblasts expressing myogenin enter differentiation phase, myoblasts start to fuse with 
other myoblasts or existing myofibers to form new myofibers (Järvinen, Järvinen et al. 2005, 
Rigamonti, Zordan et al. 2014). SCs are the primary source contributing new nuclei to the 
regenerating muscle but SCs are not the only source. The resident muscle-derived stem cells, 
another population of muscle stem cells, are able to supply myoblasts (Charge and Rudnicki 
2004). Furthermore, different types of non-muscle stem cells such as bone marrow stem 




cells are not only direct sources for myonuclei but also contributors for the muscle SC niche 
through secretion of paracrine growth factors (Quintero, Wright et al. 2009, Tedesco, 
Dellavalle et al. 2010)).  
 Early granulation tissues created by fibroblast is deposited at the site of injury and 
become a bridge to close the gap between the myofiber stumps providing the strength to 
resist original tensile forces (Hurme, Kalimo et al. 1991; Järvinen, Järvinen et al. 2005). The 
infiltrating fibroblasts synthesize ECM component proteins such as collagen and laminin to 
restore the ECM integrity (Hurme, Kalimo et al. 1991). Unlike most skeletal muscle injuries, 
volumetric muscle loss forms a dense scar tissue which becomes a barrier hindering the 
completion of muscle regeneration.   
  The innervation and vascularization in the regenerating myofibers are crucial steps in 
the functional recovery of the injured muscles (Grefte, Kuijpers-Jagtman et al. 2007). 
Angiogenesis, a formation of blood vessels from pre-existing blood vessels, occurs from the 
adjacent blood vessel branches into the injured tissues by endothelial progenitor cells. 
Reinnervation of regenerating myofibers is a critical step in order to determine myofiber 
phenotypes and recover functional capacity (Larkin, Kuzon et al. 2003). 
Remodeling phase 
 The remodeling phase following the repair phase is characterized by myofibers 
reorganization, scar tissue remodeling and functional recovery. The migration of central 
located nuclei to the periphery is a maturation process in regenerating myofibers. These 
maturing myofibers attach to the surrounding ECM and replace the pre-occupied scar tissue. 
The size of scar tissue decreases as the muscle stumps ingrowth until the regenerating 




et al. 2002). 
 These general skeletal muscle repair processes summarized above is not perfectly 
applied to recovery in large volumetric muscle loss. The VML injured muscle failing a 
completion of the repair processes results in functional deficits by denervation of the muscle 
and formation of the large scar tissue (Äärimaa, Kääriäinen et al. 2004, Crow, Haltom et al. 
2007). In this study we will examine stem cell administration and resistance training as 
therapeutic treatments to enhance functional and morphological healing process in VML 
injuries. 
 
Volumetric muscle loss 
Overview 
The large volume of skeletal muscle loss usually results in functional deficits, 
cosmetic flaws, emotional pain and a permanent handicap (Grogan, Hsu et al. 2011). VML 
arises from not only motor vehicle accidents and surgical ablation such as tumor tissue and 
diabetic tissue removal in civilians but also, gunshots and explosive substances in military 
people. This severe loss of full-thickness of a muscle creates a large gap between the end of 
the transected muscle stumps which hampers the natural regenerative process and triggers 
fibrosis (Terada 2001). As a result, the pre-occupying connective tissues obstruct myofiber 
ingrowth and blood vessel infiltration. Since a VML injury results in muscle loss as well as 
damage to nerves, blood vessels and ECM, completion of functional and morphological 
repair is still a big challenge. Therefore, the treatments for VML injuries should be 




scaffolding provides a room for ingrowth new myofibers which are capable to inosculate 
with remained myofibers. The effect of biological scaffold transplantation with myogenic 
cells is a prominent research area in regenerative medicine. 
Surgical free muscle transplantation is a common current treatment for VML. Not 
only the treatment often causes donor site morbidity and functional deficits, but also it is not 
able to apply to the removal of large volumes of muscle tissues (Norris and Kellam 1997, 
Friedrich, Katolik et al. 2011). Transplanting synthetic scaffolds is an attractive approach 
because of the high reproducibility and availability. However, synthetic scaffolds also lead 
some negative effects. Synthetic scaffolds often elicit an excessive inflammatory response 
and a further complication resulting in failure in incorporation of host tissues (Meintjes, Yan 
et al. 2011).  
 Acellular ECM and biological scaffolds composed with ECM components have been 
used to repair tissues such as cardiac muscles, skeletal muscles, and abdominal skin 
(Badylak, Geddes et al. 2003, Kochupura, Azeloglu et al. 2005). Acellular ECM preparation 
involves several processes such as tissues harvest, decellularization, and strerilization. 
Remaining small amount of DNA in acellular ECM concerns the risk of using xenogenic 
scaffolds due to immunological rejection. However, researches have shown that ECM 
component proteins appear highly conserved across species (Gilbert, Freund et al. 2009). In 
a recent clinical treatment, transplantation acellular porcine ECM  to the patient having a 
skeletal muscle injury in the quadriceps forms new muscle tissues after 36 weeks post 






Extracellular matrix as a biological scaffold 
 The ECM is a three-dimensional structure consisting of glycoproteins, heparin 
sulfate proteoglycans, glycosamnoglycans, and type IV collagen plays a critical role in 
functional and structural support of skeletal muscles (Clark, McElhinny et al. 2002). The 
ECM communicating with cells through integrin subunits regulates activation, proliferation, 
and differentiation of progenitor cells (Brzóska, Bello et al. 2006). Researches have been 
shown that the activity in myogenic cells heavily depends on ECM components, especially 
primary ECM components such as collagen, laminin, and fibronectin have been extensively 
studied. Agarose hydrogel scaffolds coupled with laminin promotes neurite extension from 
dorsal root ganglia (Yu, Dillon et al. 1999). The bioengineered hydrogel with collagen and 
fibrin increase functional properties and cellular hypertrophy (Hinds, Bian et al. 2011). On 
the other hand, inhibition of collagen synthesis restrains myoblast differentiation (Nandan, 
Clarke et al. 1990). Myogenic cells cultured on the dish coated with ECM component 
proteins promote myoblast proliferation and differentiation, especially adhered SCs to 
laminin increase motility (McFarland, Doumit et al. 1988, Siegel, Atchison et al. 2009, 
Stern, Myers et al. 2009). Duchenne’s muscular dystrophy (DMD), a disease cannot produce 
dystrophin which makes the sarcolemma brittle, illustrates the importance of ECM protein 
to muscle structural and function. Patients with DMD result in progressive muscle 
degeneration that causes premature death. 
 The elasticity of ECM is one of factors to determine stem cell lineage specification. 
MSC cultured on collagen coated plates with different elasticity, which mimicked the 
stiffness of the original tissues, differentiate into neural tissues on a soft plate, myogenic 




While MSC on stiff condition express of smooth muscle cell markers, MSC on soft 
condition express chondrogenic markers. Moreover, stem cell proliferation also depends on 
the tissue stiffness. The ratio of MSC’ proliferation in respond to TGF- β depended on the 
matrix stiffness (Park, Chu et al. 2011). 
 The ECM also serves as a storage of growth factors, and the ECM binds to and 
releases growth factors as well (Schultz and Wysocki 2009). The ECM stores growth factors 
including fibroblast growth factor (FGF), transforming growth factor-β (TGF-β), hepatocyte 
growth factor (HGF), and VEGF. During the repair phase, released chemokines from 
degrading ECM attract progenitor cells and stem cells (Beattie, Gilbert et al. 2008, Mauney, 
Olsen et al. 2010). After injures, macrophages and SCs release matrixmetalloproteinases 
(MMPs) which promote secretion of growth factors binding to ECM, and the growth factors 
released by ECM enhance progenitor cell migration and proliferation (Hawke and Garry 
2001, Lolmede, Campana et al. 2009, Schultz and Wysocki 2009). Cultured SCs under high 
TGF-β1 signaling inhibits the MyoD and Myogenin expression resulting in limitation of SC 
proliferation and differentiation (Li, McFarland et al. 2008). Single myofiber studies show 
that both HGF and FGF-2 affect SC proliferation (Yablonka-Reuveni, Seger et al. 1999).  
 Acellular ECM has prominent benefits as a scaffold since antigens, which are able to 
trigger immune response, are removed, and tissue remodeling macrophages are promoted by  
acelluar ECM transplantation (Badylak, Valentin et al. 2008). Another benefit of acellular 
ECM is biocompatibility and biodegradability which lead host cell to produce their own 
matrix (Borschel, Dennis et al. 2004). Furthermore, 3D structure of ECM retains the original 
structure of myofibers, vessels, and nerves which assist myotube alignments and the 




 Acellular ECM scaffolds seeded with progenitor cells have been extensively 
researched in VML injuries (Borschel, Dennis et al. 2004, Merritt, Cannon et al. 2010). 
Blood vessels and myofibers are displayed in an implanted homologous muscle acellular 
matrix (Marzaro, Conconi et al. 2002). The implantation acellular ECM with myoblasts 
repairs abdominal wall defects (Coppi, Bellini et al. 2006), while only homologous acelluar 
ECM implantation resulted in a large volume of fibrous scar tissues (Conconi, De Coppi et 
al. 2005). Previous studies in our lab have shown the ability of the homologous acellular 
ECM to support muscle and blood vessel regeneration (Merritt, Hammers et al. 2010), while 
implanting an acellular ECM seeded with mesenchymal stem cells improves functional 
recovery as well (Merritt, Cannon et al. 2010). 
 
Satellite cells as sources of muscle regeneration 
 SCs, adult stem cells, are primary sources for skeletal muscle regeneration. SCs 
locating between basal lamina and sarcolemma are mitotically quiescent. A hall mark of SC 
is a self-renewing capacity which has been demonstrated by SCs transplantation studies. 
Transplanted SCs into SC depleted mdx mice not only form myofibers, but also migrate to 
the host SC niche and incorporated with host fibers (Sacco, Doyonnas et al. 2008). The 
number of SCs in a single fiber associates with age and fiber types, and SCs are unevenly 
distributed along a fiber. 30~35% of nuclei in a postnatal mouse express SC markers while 
an adult mouse consists only 1~4% of SC (Schultz 1974). Soleus, a slow type of muscle has 
two- to threefold SCs than extensor digitorum longus , a fast type of muscle (Gibson and 
Schultz 1982, Snow 1983). The population of SC is heterogenous in mammalians such as 




Rossi, Pozzobon et al. 2010). High density of SC has been observed adjacent to capillaries 
(Schmalbruch and Hellhammer 1977) and close to motor neuron junction (TENNYSON, 
KREMZNER et al. 1973) which imply they contribute to SC character. SCs are 
characterized by distinct markers in each sequential step. Quiescent SCs are characterized 
by Pax7, paired box7, which plays a key role in SC development and lineage determination. 
Pax7- null mice appear 50% decrease in body weight at 7 days of age, even pax7-null mice 
die within 2 weeks after birth (Jostes, Walther et al. 1990, Seale, Sabourin et al. 2000).  
Growth factors play a major role in SC proliferation and differentiation. IGF-1 is a 
well-known growth factor for skeletal muscle regeneration. IGF-1 is able to change the 
expression of myogenic regulatory factors and elevate the proliferation of SC (Allen and 
Boxhorn 1989, Charge and Rudnicki 2004). HGF leads SC migration to the site of damage 
(Bischoff 1997) and SC proliferation by binding to c-met (Allen, Sheehan et al. 1995). In a 
process of muscle regeneration, SCs exposed to the muscle injury start proliferating by 
multiple cellular and molecular responses governing SC environment. Activated SCs, they 
are often referred to myoblasts, are characterized by the upregulation of Myf5 and MyoD 
(Cornelison and Wold 1997, Cooper, Tajbakhsh et al. 1999, Zammit, Heslop et al. 2002). 
MyoD upregulation relates to SC proliferation, and SC differentiation depends on MyoD 
downregulation. MyoD-null mice have shown a limited regenerative capacity characterized 
by abnormal myoblasts morphology (Sabourin, Girgis-Gabardo et al. 1999) and a decrease 
in regenerating myofibers (Megeney, Kablar et al. 1996). When SCs enter the differentiation 
phase, Myogenin and Myf 6 are highly expresse (Grounds, Garrett et al. 1992, Cornelison, 
Olwin et al. 2000). Myogenin is essential for the fusion of myoblasts either themselves or 




and express contractile protein such as actin and myosin. On the other hand, Myogenin-null 
mice have only a few myofibers at birth, and they die prenatally (Hasty, Bradley et al. 1993, 
Nabeshima, Hanaoka et al. 1993, Venuti, Morris et al. 1995). 
The probability of SC transplantation for muscle regenerative medicine has been 
extensively studied. Donor cells derived myofibers are investigated by donor gene 
expression in host tissues (Collins, Olsen et al. 2005, Montarras, Morgan et al. 2005). Donor 
SCs not only fuse with themselves or host myofibers, but also exist as SCs within 
regenerating myofibers through self-renewal (Collins, Zammit et al. 2007, Sacco, Doyonnas 
et al. 2008). 
 
Myofibers as a source of satellite cell 
 SCs are primary sources to contribute skeletal muscle regeneration. Enzymatically 
dissociated SC transplantation has a challenge to resolve skeletal muscle wasting disorders 
(Mouly, Aamiri et al. 2005, Tedesco, Dellavalle et al. 2010) because enzymatically 
dissociated and transplanted SCs result in limited muscle regeneration due to limited 
migration of SC, donor-host histocompatibility, and early death of donor SCs. Individual, 
freshly isolated single myofiber transplantation is an alternative way to deliver SCs to 
damaged muscles. SC delivery though individual single fiber transplantation keep SC 
stemness because SCs are influenced by the original environment which increase survival 
ratio of donor SCs. Individual myofiber contains 7-22 of SCs in a mouse (Seale, Sabourin et 
al. 2000, Zammit, Heslop et al. 2002), and SCs migrate from the fiber to the damaged site. 
Single myofiber containing 7 SCs generated more than 100 new fibers containing 25,000-




hypertrophy as well as an increase in CSA (Boldrin and Morgan 2013). Single myofiber 
transplantation not only results in hypertrophy with high force production, but also donor 
fiber derived SCs in young age remain in a host muscle permanently which prevents age-
related mass reduction (Hall, Banks et al. 2010). A previous study in our lab, transplanting 
50 myofibers into pre-embedded ECM results in an increase in the number of regenerating 
fiber and a decrease in decullularized area in a VML rat. 
 
Resistance training and regeneration 
 Resistance training (RT) influences on the functional properties in skeletal muscles 
by modifying fiber structure, mass, metabolism and promoting the release of growth factors. 
The intensity and mode of exercise induce specific adaptation of skeletal muscles. RT 
potentially increases muscle mass and contractile properties. After 6 weeks of heavy 
resistance training, muscle strength increases by 15% (Aagaard, Simonsen et al. 2002). RT 
enhances muscle protein synthesis ratio in human by 50% at 4 hours after a heavy resistance 
training (MacDougall, Gibala et al. 1995). RT plays an important role in not only myofiber 
hypertrophy, but also regenerative capacity (Fry 2004, Folland and Williams 2007). The 
number of SC increases by 17% after extreme 16 weeks of resistance training (Petrella, Kim 
et al. 2008). Power lifters containing higher number of SC response to injuries acutely 
(Thornell, Lindström et al. 2003).  
RT is one of the best treatments for VML injury because VML results in severe 
functional deficits. 10% of the mass of the muscle loss results in 30% of initial peak 
isometric force reduction (Chen and Walters 2013). When 20% of the mass of the TA is 




(Corona, Wu et al. 2013). Therefore, VML patients require a special treatment to enhance 
functional recovery. Low intensity exercise is beneficial to repair of the cardiac tissue 
(Herdy, Marcchi et al. 2008), and high intensity exercise attracts circulating mesenchymal 
stem cells in myocardial ischemia patients (Lucia, De La Rosa et al. 2009). Both resistance 
and endurance training trigger angiogenesis and vascularization (Green, Goreham et al. 
1999, Laughlin and Roseguini 2008). This vascularization is a particular concern in 
repairing or regenerating tissues in order to attract residence and circulating cells. Moreover, 
Blood vessels provide nutrients and oxygen to support muscle reconstruction (Teixeira, 
Zamuner et al. 2003). 
 
Innervation and vascularization of the ECM 
 New myofiber formation should synchronize with vascularization and innervation 
together because of the role of blood vessels and nerves in skeletal muscles. Transmission of 
nerve impulses causes skeletal muscle contraction. A nerve fiber consists of axons and 
myelin sheath is characterized by central nerves and peripheral nerves. Especially, both 
motor nerve fibers and sensory nerve fibers involving peripheral nerves directly supply 
muscle contraction. Innervation plays an important role in functional morphological skeletal 
muscle maintenance (Borisov, Dedkov et al. 2005). Denervated skeletal muscles continue 
the path of degeneration due to the failure of neuromuscular junctions which results in 
atrophy and tissue necrosis (Järvinen, Järvinen et al. 2005). Skeletal muscle regeneration 
occurs following denervation, but this process is not able to continue by SC depletion 
(Borisov, Dedkov et al. 2005). Since denervation results in adverse effects on the muscle, it 




Schann cells, the primary glia of the peripheral nerve fiber, perform nerve regeneration and 
muscle innervation. Activated Schann cells secrete cytokines and neurotrophic factors that 
guide axon growth (Shimizu, Kitada et al. 2007). Innervation by axons depends on the 
remaining Schann cell tubes, as well as Schwann cell extension processes leading to end 
plates (Son and Thompson 1995). The presence of motorneurons affects Schann cell 
viability. Motor neurons secrets neuregulins, glial growth factors, that promotes survival and 
proliferation of Schann cell (Trachtenberg and Thompson 1996, Kopp, Trachtenberg et al. 
1997). The effects of neuregulin on muscle by binding tyrosine kinase receptors have been 
observed. Human myoblasts cultured with neuregulin express an increase in acetylcholine 
receptors and myosin heavy chains (Jacobson, Duggan et al. 2004). Other studies have 
researched the role of neurotrophic factors such as nerve growth factor (NGF), 
neurotrophin-3(NT-3), and brain-derived neurotrophic factor (BDNF) on skeletal muscle 
regeneration. NGF is important for the survival and growth of neuron. Phenotypic 
characterization of NGF knockout mice increases in cell death and muscle dystrophy 
(Ruberti, Capsoni et al. 2000). NGF treated with laminin and Muscle-derived stem cells 
enhances enhance neurite extension and the engraftment efficiency respectively (Yu, Dillon 
et al. 1999, Lavasani, Lu et al. 2006). NT-3, a neurotrophic factor, encouraging the growth 
of the nerve modulates neurogenesis. Transgenic mice for NT-3 overexpression increase the 
number of sensory and motor neuron, and NT-3 delivery enhances axonal regeneration in 
denervated muscle (Taylor, Vancura et al. 2001). BDNF supports the survival of existing 
neurons and promotes growth and differentiation of new neurons (Acheson, Conover et al. 
1995, Huang and Reichardt 2001). BDNF also influences on skeletal muscle regeneration. 
BDNF depleted mice display a decrease in Pax7 positive cells, as well as impair skeletal 




skeletal muscle cells in skeletal muscle regeneration.  
Blood vessels supply nutrients and oxygen to muscle tissues. The diffusion distance of 
oxygen and nutrients from micro vessels to cells is only limited to 150-200 µm (Carmeliet 
and Jain 2000). Even though immediate hypoxia condition triggers endothelial cell 
proliferation (KIEFER, BERNS et al. 2002), muscle tissue are not able to survive without 
blood supply in a long term. Endothelial cell (EC)s located the interior surface of blood 
vessels are involved in vascular biology. EC transplantation in myocardial injury stimulates 
angiogenesis which results in an increase in regional perfusion (Kim, Kwon et al. 2001). 
Vascular endothelial growth factor (VEGF) is a primary regulator of angiogenesis. VEGF 
derived angiogenesis promotes skeletal muscle regeneration. VEGF overexpression via 
virus gene transfer shows an increase in forelimb strength and an decrease in necrotic fibers 
area in mdx mouse (Messina, Mazzeo et al. 2007). Combined delivery of VEGF and IGF-1 
led to angiogenesis, innervation, and SC activation which results in functional recovery 
(Borselli, Storrie et al. 2010). In a previous research in our lab, transplantation of 












Skeletal muscles have an ability to heal in general injuries, but skeletal muscles are 
not capable of regenerating across a large gap. The repercussions of this severe injury cause 
subsequent functional deficits due to loss of nerves, vessels and muscle mass. Moreover, 
people who sustain VML injury suffer from emotional distress by physical abnormalities 
and aesthetic deficits. Physical and psychological rehabilitative processes cost large amount 
of money. General current clinical treatments transplanting only biocompatible matrix or 
autologous acellular ECM have not yet completed functional and morphological recovery. 
Preliminary researches in our lab showed the probability of functional and morphological 
recovery in a VML rat with mesenchymal stem cells (Merritt, Cannon et al. 2010) and nerve 
relocation treatments (Tierney et al., 2010, unpublished), but still lots of fibrotic tissues exist 
within ECM, and mechanical properties are not fully recovered. SC transplantation for 
skeletal muscle regeneration is a very commonly researched treatment. Delivery of SC 
through single myofiber has shown functional recovery and hypertrophy in mdx mice not a 
naïve animal model (Collins, Olsen et al. 2005; Hall, Banks et al. 2010; Boldrin and Morgan 
2013). Resistance training is a well- known treatment to trigger hypertrophy and an increase 
in muscle mass, but the potential interaction between resistance training and muscle cell 
activation should be studied. Therefore, the findings in this study will suggest the 









Male fisher 344 rats (Charles River Laboratories; Wilmington, MA), about 400g of 
weight, were used in this study. F344-Tg (UBC-EGFP) was used for a myofiber donor. 
Animals were housed on a 12 hour light/dark cycle room and given ad-libitum access to 
food and water. Rats were randomly assigned to one of four groups (n=8). Rats were 
evaluated functionally after 56 days of recovery from initial defect surgery. All experimental 
procedures were conducted in accordance with guidelines set by Institutional Animal Care 
and Use Committee (IACUC). 
 
ECM decellularizaton 
Extracellular matrices from the porcine decellularized in a method similar to Merrit, 
but with modifications (Merritt, Cannon et al. 2010). Fat and connective tissues were 
excised from muscles and cut into small pieces. Deionized water (dH2O) was injected 
throughout the whole muscles and the muscles placed in dH2O for 2 hours to allow for 
cellular swelling and rupture. PBS was injected throughout the entire muscles, and the 
muscles were placed in PBS for 2 hours. 0.25% Trypsin-EDTA(Gibco
®
 Life Technologies,) 
was injected throughout the entire muscles, and the muscles were placed in an oven for 45 
minutes at 37°C. The tissues were then placed in a glycerol (Fisher; Pittsburgh, PA), 
disodium ethylenediaminetetraacetate dehydrate (EDTA) (Bio-Rad Laboratories; Hercules, 
CA), deoxycholic acid (Fisher; Pittsburgh, PA), and sodium dodecyl sulfate (SDS) (Sigma-




machine with Tris base (Fisher; Pittsburgh, PA), Glycine (Fisher; Pittsburgh, PA), and SDS 
(Sigma-Aldrich; St. Louis, MO) solution at a constant voltage of 60V for 24 hours. 2% SDS 
was injected though the muscles, and then the muscles were placed in SDS for 6 hours. The 
electrophoresis process was repeated until all cellular materials were eliminated. The ECM 
was rinsed in dH2O until water looked clear. The ECM was placed in sterile phosphate 
buffered saline (Invitrogen; Carlsbad, CA) 1% antibiotic-antimycotic (Sigma-Aldrich;St. 
Louis, MO) (1% AA) overnight on a shaker. Next, the ECM was placed in 70% ethanol for 
4 hours, subsequently placed in PBS 1% AA and exposed to ultraviolet light overnight. 
Decellularized ECMs were stored at 4°C in sterile PBS with 1% AA until use in 
implantation. 
 
VML creation & ECM implantation 
Prior to VML surgery, all animals were randomly assigned to one of four 
experimental groups: implantation of the ECM (ECM), implantation of the ECM followed 
by myofiber injection (FIB), implantation of the ECM followed by resistance training 
(EXE), and implantation of the ECM followed by myofiber injection and resistance training 
(FIB+EXE). All animals underwent removal of about 20% of muscle mass from the lateral 
gastrocnemius (LGAS). An piece of the same dimensions of ECM was transplanted 
immediately, and myofibers were injected seven days later as described by Collins(Collins, 
Olsen et al. 2005). All surgeries were conducted with aseptic tools while rats were 
anesthetized with 2-2.5% isoflurane gas. 
Briefly, a two-centimeter incision was made along the lateral side of the right lower 




biceps femoris. The soleus was gently separated from the LGAS by blunt forceps. A metal 
plate was placed between the soleus and the LGAS to prevent injury to the soleus upon 
creation of LGAS defect. Two #9 scalpel blades separated 1 cm by a spacer was used to 
create the equal shape of defect to all animals. Approximately, 1.0 x 1.0 cm full thickness 
with 20% of mass of the LGAS was excised. Immediately following defect, an ECM was 
prepared to the same dimension of the excised muscle and implanted to the site of injury 
using a nonabsorbable 5-0 polyprolene (5-0 prolene; Ethicon) suture. The ECM was fixed 
with A modified Kessler’s stitch with simple interrupted sutures on three borders. The 
sutures were used as markers to distinguish between original tissues and regenerating tissues 
for histological and immunohistological analysis (Kragh Jr, Svoboda et al. 2005). The 
biceps femoris was closed using simple interrupted polyprolene sutures (5-0 prolene; 
Ethicon). The skin was sutured via a simple interrupted suture (5-0 prolene; Ethicon) with 
the knot tied underneath the skin. 
 
Myofiber isolation  
EDL was digested by filtered 1.5% Collagenase type I in DMEM for 2 hours at 37°C 
and 5% CO2. During digestion EDL was gently shook every 30 minutes. When single 
myofiber detaches from the EDL, EDL and single fiber were transferred to a prewarmed 
Petri dish with DMEM. Single myofiber was isolated by pipetting. 
  
Treatment surgery 




increase the survival ratio of injected fibers. The original stiches were removed to expose 
and visualize the ECM. GFP-myofibers were isolated from F344-Tg (UBC-EGFP). 30 
myofibers were injected evenly though the entire injury area using a 28.5-gauge needle with 




Exercise treatments groups, EXE and FIB-EXE, began resistance training at 7 days 
post defect surgery. This time was given to allow for ECM adhesion with the injury site and 
force transmission across the defect (Kjær 2004). Rats were subjected to climb a ladder 
every third day for 6 weeks. The ladder was 1-m height with 2-cm steps and inclined at 85% 
degree. Rats were familiarized with the ladder by climbing the ladder three times for three 
days before a surgery. The weights were attached to the proximal tail, and the initial weight 
attached to a rat was 50% of body weight. The animals were encouraged to climb the ladder 
by gently touching the tail and pushing the behind. When rats completed climbing the ladder, 
they were allowed to take 2 minutes rest in a simulated cage at the top of the ladder 
apparatus. The load was set at 50, 75, 90, and 100% of maximum load from the previous 
session. When a rat was able to climb with 100% of maximum load, 30g of weight was 
added subsequently until the rat failed to climb the ladder. 
 
Functional analysis 




on both contralateral and experimental legs. Animals were anesthetized as previously 
described, and both legs were shaved. A skin incision was created 2-cm below and parallel 
to the femur to expose a sciatic nerve. The sciatic nerve was severed as close as possible to 
the hip to secure an enough length for an electrical stimulation. A longitudinal skin incision 
was created at the posterior portion of the leg from the calcaneus to the head of 
gastrocnemius (GAS). A biceps femoris incision was made like a skin incision from the 
calcaneus to the head of gastrocnemius. A nerve branch for medial gastrocnemius was cut to 
allow only force generation from LGAS. The calcaneus was cut with the Achilles tendon to 
separate the GAS from the tibia. Plantaris and soleus were separated from the GAS to 
ensure that the LGAS was an only subject to contribute to force production. A 1/16
th
 inch 
drill bit was penetrated the posterior portion of the tibia head to fix GAS head. The Achilles 
tendon tied to the level arm (model 310-B, Aurora Scientific, ON, Canada). The severed 
sciatic nerve was placed on electrodes and stimulated by a stimulator (Model 2100; A-M 
Systems, Carlsborg, WA). Mineral oil was used to prevent the LGAS and sciatic nerve from 
drying and a heat lamp was used to maintain the muscle temperature between 36.5 and 
37.5°C. Optimal length was set and maximal tetanic contraction was measured at 150Hz and 
the minimal voltage to elicit maximal tetanic contraction. Tetanic contraction was separated 
by 2 minutes of rest. The process was applied to the contralateral leg. After force 
measurement was completed, the LGAS and MGAS were excised, weighted, and measured 
a length to calculated specific tension. All muscles were frozen in liquid nitrogen and stored 






LGAS were sectioned into 10 μm sections perpendicular to the LGAS orientation 
with a Leica CM1900 cryostat microtome (Leica Microsystems; Wetzlar, Germany) at -20°C. 
Hematoxylin and eosin (H&E) (Thermo Fisher Scientific) staining were performed to 
identify intact fibers and regenerating fibers. Masson’s trichrome (Polysicence) was used to 
define myofiber and fibrous connective tissue area. Sections were mounted with permount 
mounting medium (Fisher Scientific; Waltham, MA). Sections were visualized with a Nikon 
Diaphot microscope with an Optronix Microfire digital camera. Histological quantification of 
H&E was performed on each level with the 20x objective lens. 
 
Immunohistochemical analysis 
Series of 10 μm cross sections were taken from top, middle and bottom regions of the 
LGAS muscle. In preparation for immunofluorescent identification, sections were fixed in 
acetone for 3 minutes. After which, they were washed in phosphate buffered saline (1X, PBS) 
and blocked with 5% normal donkey serum in PBS containing 1% bovine serum albumin 
(BSA). Sections were first incubated with primary antibodies against PECAM-1 (1:20, mouse 
monoclonal) and neurofilament 200 (1:200, rabbit polyclonal). PECAM-1 was detected with 
donkey anti‐mouse IgGTRITC fluorescein (1:100, λ=546 nm) and neuofilament 200 was 
detected with anti‐rabbit‐Alexa 488 (1:100, λ= 495 nm). Finally, all sections were 
counterstained with DAPI (1:1000, λ=425 nm) to identify nuclei. Following a final series of 






Imaging and analysis 
Immunofluorescence was visualized with a Leica DM LB2 fluorescence microscope 
and photographed with a Leica DFC340FX digital camera (Leica Microsystems; Wetzlar, 
Germany). At each level and within each region of the ECM, the number of nerve and vessels 
was counted using Image J and expressed as a percentage of the total number of blood vessels 
and nerves in the ECM area. 24 vessels were counted in each image and expressed as the 
number of blood vessels present per unit area of the ECM (#/mm2). A vessel was only 
counted if its lumen was greater than 20 μm in diameter. 
Statistical analysis  
Data has been represented as mean ± SEM. One-way ANOVA was used for analysis 
of group samples. Comparisons between groups made using Tukey’s post hoc tests. Statistical 













 The average mass of the removed muscle was 176 ± 16 mg wet weight 
approximately 20 % of the total mass of the LGAS, the defect mass was approximated by 
body weight. Overall morphology of the LGAS was flat on defected side compared to a 
contralateral limb. Previous work in our lab using homologous ECM transplantation, the 
morphology of the LGAS was well maintained following 56 day recovery (Merritt, Cannon et 
al. 2010), but transplantation of porcine ECM was not maintained original round shape. The 
sum of the injured LGAS mass and originally removed muscle mass was 99.4% ± 1.7 % of 
the mass of the contralateral LGAS. 
 Histological analysis following 56 days of recovery demonstrated small myofiber 
growth within the ECM and regenerating fibers with central nuclei (Figure 3). Both small 
myofibers and myofibers containing central nuclei mean these fibers are in the processes of 
regenerating and maturing. Especially, a large size of myofiber with central nuclei was 
located at the border between the ECM and intact muscles (Figure 3). CSA was measured in 
uninjured area to investigate compensatory hypertrophy and resistance training effect (figure 
4). EXE group (5122±92μm
2





), and FIB+EXE (47642±97μm
2
) groups (Figure 5). 
 Immunohistochemical analysis showed neurogenesis and angiogenesis of the ECM. 
Neurofilament staining revealed the presence of innervation at regenerating area filled with 
central nuclei myofibers (Figure 6). However, nerves were not detected in the middle or 
peripheral of the ECM where no mature fibers exist. Quantification of total number of nerves 
through in the entire area showed no significant differences between groups (Figure 7A). 






was dominant in all groups. PECAM staining showed angiogenesis at regenerating 
area filled with central nuclei myofibers, and in the middle of ECM filled with small 
myofibers and fibrotic tissues (Figure 8). Quantification of the number of blood vessel larger 
than 20μm in the entire area showed a significant difference in EXE group (46±4.2) 
compared to ECM group (35±3.89) (Figure 9 A). EXE group (34±3.2) significantly increased 
the number of blood vessel in regenerating area compared to ECM group (22±3.3). 
 In previous research in hour lab, the middle region of ECM did not repair well than 
top and bottom regions. Fibrous connective tissues were measured by Masson’s trichrome 
staining. A significant difference in connective tissue area in middle region of the ECM was 
quantified between EXE (45±1.6%) and ECM (69±1.9%) groups (Figure 10). Moreover, 
small muscle fiber area within ECM was significantly higher in EXE group (1.39±30.15 μm
2
) 
than ECM and FIB groups (0.67±0.15μm
2
) (Figure 11). Although EXE group tended towards 
a higher number of blood vessel and nerve compared to other groups, this difference was not 












The large volume of skeletal muscle loss usually results in functional deficits, 
cosmetic flaws, and a permanent handicap. Associated psychological distress ensues from 
functional deficits and cosmetic flows accompanied with traumatic injuries. Current therapies 
can improve myofiber infiltration and functional properties, but fail to limit fibrosis and fail 
to improve angiogenesis and myofiber infiltration into middle region of the ECM. Therefore, 
it is imperative to develop a therapy that is able to improve myofiber infiltration through 
entire regions in ECM. 
This study tested whether the combined effect of myofiber injection and resistance 
training on a VML injury. The results show only EXE group produces positive effects on 
skeletal muscle regeneration after 8 weeks of recovery. EXE group increases 15.7% of mass 
recovery significantly compared to DEF group. RT potentially increases muscle protein 
synthesis ratio, muscle mass, and contractile properties. Ladder climbing training has resulted 
in a 5–26% increase in muscle mass (Ho, Roy et al. 1980, Duncan, Williams et al. 1998, 
Hornberger Jr and Farrar 2004). Several muscle groups can be affected by ladder climbing 
including the soleus, plantaris, and gastrocnemius (Ho, Roy et al. 1980, Duncan, Williams et 
al. 1998, Hornberger Jr and Farrar 2004). In previous research in our lab, 8 weeks of ladder 
climbing increases 23% of mass and 14% of tetanic tension in flexor hallucis longus muscle 
(Lee, Barton et al. 2004). Moreover, muscle hypertrophy induced 6 weeks of ladder climbing 
in VML injured LGAS results in 11% of mass and 16% of functional recovery more than 
only ECM treated group (Taejeong Song et al. 2015, unpublished).  
Transmission of nerve impulses causes skeletal muscle contraction. Innervation plays 




et al. 2005). Since denervation results in adverse effects on the muscle, it is essential that 
regenerating muscle fibers should accompany with innervation in a VML injury. A 12-week 
high resistance training has a slowly progressive effect on neuromuscular diseases (Kilmer, 
McCrory et al. 1994). Resistance exercise induces a robust elevation of circulating BDNF 
(Yarrow, White et al. 2010). Previous studies in our lab reveal that the ECM can provide a 
room to support cellular myofiber, and blood vessel growth, therefore we postulate that 
resistance training triggers innervation into ECM. In this experiment, EXE and FIB+EXE 
groups tend to have higher number of nerve, but the difference is not significant. Innervation 
only occurs regenerating area containing mature size of myofiber. Neurofilament staining 
does not detect nerve like-structures with in ECM containing small myofibers or connective 
tissues. The innervation is the last step in skeletal muscle regeneration process that affect 
myofiber maturation and functional recovery (Musarò 2014). This study shows that ECM 
constructs have the capability of allowing innervation as muscle tissues become mature.  
Blood vessels supply nutrients and oxygen to muscle tissues. In a previous research 
in our lab, transplantation of ECM alone or with mesenchymal stem cells increases blood 
vessel density. It means that the transplanted ECM is able to process angiogenesis. In this 
study, EXE group contains significantly higher number of blood vessel than ECM group in 
both regenerating area and entire area. Resistance and endurance training trigger 
angiogenesis and vascularization (Green, Goreham et al. 1999; Laughlin and Roseguini 
2008). Exercise training has been showed an increase in capillary density by VEGF (Amaral, 
Papanek et al. 2001) and endothelial progenitor cells (Laufs, Werner et al. 2004). Resistance 
training also increase capillaries per fiber (McCall, Byrnes et al. 1996).   




fibrosis and an increase in regenerating small muscle fibers in a middle region of the ECM. A 
repair of VML injury with an only ECM implantation results in deficient recovery associated 
functional loss and insufficient myofiber infiltration into middle region of ECM (Merritt, 
Hammers et al. 2010). Although the implanted ECM bridges the gap, the infiltrating 
myofibers and blood vessels are limited to top and bottom regions which are close to 
uninured muscle. RT influences on the remodeling of ECM, and RT is effective SC 
proliferation (Darr and Schultz 1987, Mackey, Esmarck et al. 2007). Continuous RT in every 
three days keeps triggering proliferation of SC, which helps myofiber infiltration into the 
middle region of the ECM.  
The combined treatments do not have an additive effect. Even though the significant 
difference does not find between EXE and EXE+INJ group, EXE group tend to recover more 
LGAS muscle mass. EXE group recover 87.6% of LGAS mass while EXE+INJ groups 
recover only 75.2% of LGAS mass. After 6 weeks of resistance training EXE group climb the 
ladder with 227% of body mass while EXE+INJ group climb the latter with 187% of body 
mass. EXE group significantly lifts more weight compared to EXE+INJ group. EXE+INJ 
receives surgeries twice, a defect surgery and a surgery for fiber injection, which may trigger 
additional damage. 
In summary, this study proves that the treatment of a VML injury with continuous RT 
following ECM implantation significantly effects on histological and morphological recovery 
over ECM implantation alone. Future studies may combine resistance training with MSC to 
examine the additive effect. Also, long term resistance training need to be examined because 
56 day of recovery time does not seem enough to complete of muscle regeneration in 20% 






Figure 1: Schematic diagram of surgical procedures in VML injury model.  
Uninjured LGAS. B.) Creation of 1x1cm VML injury. C.) ECM transplantation. D.) 
Mark injury area by using a modified Kessler stitch. E.) Injection of GFP single myofiber, 
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-2 Familiarization 29 Lift 7 
-1 Familiarization 30  
1 Defect Surgery 31  
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3  33  
4  34  
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7  37  
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1. Entire Region 
     
 
Figure 3: Masson’s trichrome staining. Sections showing myofiber infiltration and fibrotic 
tissue growth in implanted ECM taken with 2.5x, 5x, and 10x objective lens. (1.) ECM. (2.) 
FIB. (3.) EXE. (4.) FIB+EXE. A.) Entire muscle B.) Regenerating muscle C.) Regenerating 






Figure 4: Hematoxylin and eosin staining. H&E sections showing intact muscle CSA 







Figure 5: Cross sectional area in uninjured myofiber. CSA was determined through 
Hematoxylin & Eosin staining. * denotes significant difference compared to ECM. † Denotes 
significant difference compared to FIB only. ‡ denotes significance compared to EXE group. 









Figure 6: Neurofilament staining. Innervation observed via Neurofilament staining in 
regenerated muscle area closed to regenerating region, image taken with 20x objective lens. 







Figure 7: Total number of Nerves and size distribution. A.) Total number of nerves was 
counted through Neurofilament staining. B,) Nerve size distribution was determined. * 
denotes significant difference compared to ECM. * denotes significant difference compared 
to ECM. † Denotes significant difference compared to FIB only. ‡ denotes significance 
compared to EXE group. § denotes significance compared to FIB+EXE Significance is set at 








Figure 8: PECAM staining. Angiogenesis observed via PECAM staining in regenerating 
muscle area, images taken of blood vessels ≥ 20μm diameter (A.) ECM. (B.) FIB. (C.) EXE. 








Figure 9: Number of blood vessel. A.) Total number of blood vessel was counted through 
entire area. B.) Blood vessel number was determined in regenerating muscle area, images 
taken of blood vessels ≥ 20μm diameter. * denotes significant difference compared to ECM. 
† Denotes significant difference compared to FIB only. ‡ denotes significance compared to 






2. Middle Region 
 
Figure 10: Fibrotic tissue density in Middle region of VML. Fibrosis observed via 
Masson’s trichrome staining in regenerating muscle area. * denotes significant difference 
compared to ECM. † Denotes significant difference compared to FIB only. ‡ denotes 
significance compared to EXE group. § denotes significance compared to FIB+EXE 





Figure 11: Small myofiber density in Middle region of VML. Myofiber ingrowth was 
observed in regenerating muscle area. * denotes significant difference compared to ECM. † 
Denotes significant difference compared to FIB only. ‡ denotes significance compared to 








Figure 12: Total number of nerve and size distribution in Middle region of VML. A.) 
Total number of nerves was counted through Neurofilament staining. B,) Nerve size 
distribution was determined. * denotes significant difference compared to ECM. * denotes 
significant difference compared to ECM. † Denotes significant difference compared to FIB 
only. ‡ denotes significance compared to EXE group. § denotes significance compared to 









Figure 13: Blood vessel density in Middle region of VML . Blood vessel number was 
determined in regenerating muscle area, images taken of blood vessels ≥ 20μm diameter. * 
denotes significant difference compared to ECM. † Denotes significant difference compared 
to FIB only. ‡ denotes significance compared to EXE group. § denotes significance compared 




Appendix A: Expended Methods 
Ⅰ.Extracellular matrix decellularization 
1. Remove connective tissue and fat from porcine tissue, and cut into smaller pieces. 
2. Inject dH2O throughout the entire tissue, and leave in a dH2O filled container for 2 
hours, and place on an orbital shaker. 
3. Discard dH2O, Inject dH2O throughout the entire tissue, and leave in a dH2O filled 
container for 2 hours, and place on an orbital shaker. 
4.  Discard PBS, inject trypsin throughout the whole tissue, fill a container with enough 
trypsin to immerse the tissue, and place in oven for 45 mins at 37°C. 
5.  Discard trypsin, and fill in PBS for 2 hrs 
6.  Discard PBS, inject glycerol solution throughout the entire tissue, and place in a 
container with enough glycerol.  
7. Place on shaker for 48 hrs at room temperature. It is able to keep at 4°C for a long 
time ) 
8. Discard glycerol, and wash with dH2O 
9. Run in an electrophoresis machine with tris-glycine solution at 60V for 24 hrs. 
10. After running electrophoresis, inject 2% SDS throughout the tissue, and place in 2% 
SDS on an orbital shaker for at least 6hrs. 
11. Change the tris-glycine solution before running electrophoresis again. 




13. Store cleared tissues in 2% SDS. 
14. Rinse in dH2O again, repeat several times until water looks clear. 
15. Place tissues in PBS with 1% AA overnight on a shaker. 
16. Place tissues in 70% ethanol for 4 hours. 
17. Place tissues in PBS with 1% AA overnight under UV light. 
 
Ⅱ. Volumetric Muscle Loss Surgery: 
1. Before starting surgery, autoclave all surgical instruments that will directly contact 
the animal. 
2. The animal should be observed and recorded in every 15 minutes through entire 
surgical procedure. 
3. Weigh and anesthetize the animal with 2.5% of isoflurane infusion. The animal 
should exhibit absence of toe pinch reflection and normal breathing. 
4. Shave the hindlimb where the defect will be created. 
5. Create a 2cm incision with a scalpel on the lateral side of leg, parallel with the tibia. 
6. Separate the biceps femoris to expose the LGAS 
7. Gently make a space between the LGAS and soleus, and place an aluminum foil plate 
in which LGAS defect will be created to prevent soleus from injury. 




9. Create 20% mass of the full-thickness defect from distal to the neuromuscular 
junction by two scalpel blades separated by 1cm spacer.  
10. Weigh the excised muscle and create small size of defect until 20% mass is removed. 
11. Prepare a same dimension of ECM to the defect and implant it into the defected site. 
12. Suture the ECM using a modified Kessler stich with non-absorbable 5-0 polyprolene 
sutures. 
13. Stitch simple sutures at the borders of the ECM and LGAS to mark the edges of the 
ECM 
14. Suture the biceps femoris using simple interrupted sutures and the skin incision with 
the knot tied underneath the skin to prevent the animal from biting the knot. 
15. Return the animal to a cage and monitor until the animal has recovered consciousness 
16. Give subcutaneous analgesic, Rimadyl, .01ml/g at 12 hrs, 24, and 48 post surgery. 
 
Ⅲ. Single Fiber Isolation: 
1. For the purpose of these experiments, 8 week old F344-Tg (UBC-EGFP) were used. 
2. Filter 1.5% Collagenase type I in DMEM (Dulbecco's modified Eagle's medium; high 
glucose, L-glutamine with 110 mg/ml sodium pyruvate) through 0.22 μm filter.  
3. Prewarm a solution at 37 °C in a water bath before the isolation. 




skin and hairs with forceps 
5. Cut through the fascia with fine scissors without damaging the underlying Tibialis 
Anterior (TA). The EDL is found underneath TA. 
6. Expose the distal tendons of EDL and TA and cut them with sharp scissors. 
7. Hold the distal part of TA and EDL muscles by their tendons and slowly pull the muscles 
up without stretching towards the proximal. 
8. Gently pull the EDL and TA tendons in opposite directions avoiding damage in EDL 
9. Transfer EDL to 2 ml of previously prewarmed collagenase solution and place it in 
incubator set at 37°C and 5% CO2. 
10. For two EDL isolations (one mouse) prepare five plastic Petri dishes (60*15mm) as 
follows: 
11. Prepare six Petri dishes for the isolation (1 for muscle dissociation, 5 for serial washes). 
All dishes must be coated with horse serum to prevent myofibers from attaching to 
plastic. 
12. Let it dry for 30 minutes and prewarm DMEM at 37°C 
13. Check the muscle and gently shake the muscles in every 30 minutes. Stop the digestion 
when enough number of single myofiber separate from the EDL. Carefully transfer EDL 
and myofibers to a prewarmed Petri dish with 4 ml of DMEM (dissociation dish).  
14. Transfer single myofiber to DMEM to wash debris and keep it in incubator set at 37°C 




Ⅳ. In Situ Functional Analysis: 
In situ force measurements were performed on both the experimental leg and the 
contralateral leg following 56 days recovery. CSA and specific tension (SPO) of the 
muscle were calculated using the peak tension, weight and length of the lateral 
gastrocnemius.  
Protocol 
1. Weigh and anesthetize the animal, and shave both experimental and contralateral 
hindlimbs. 
2. Create a 2 cm skin incision parallel and 2 cm below to the femur to expose the biceps 
femoris 
3. Locate the origin of the biceps femoris and separate the connective tissue with forceps 
until they go through the biceps femoris. 
4. Separate the tissue using hemostats until you can locate the sciatic nerve. 
5. Carefully cut the biceps femoris along the femur towards the hip. 
6. Isolate the sciatic nerve from surrounding musculature and cut the nerve as close to the 
hip as possible. 
7. Very carefully remove any remaining tissue from the sciatic nerve and tuck it back into 
place. 
8. Make an incision along the midline of posterior portion of the lower limb from the 




9. Separate the skin from the biceps femoris, and cut the biceps femoris similarly to the 
skin to expose the LGAS. 
10. Isolate the gastrocnemius from the biceps femoris. 
11. Carefully dennervate the MGAS. This will ensure force will be measured only in the 
LGAS. 
12. Cut the calcaneus so that the distal portion of the gastrocnemius and Achilles tendon 
are still attached. 
13. Separate the soleus and plantaris from the GAS by cutting the distal insertions. 
14. Using the calcaneus to hold it in place, tie the Achilles tendon to the muscle lever arm 
of the dual-mode servometer. 
15. To stimulate the LGAS, place electrodes connected to a muscle stimulator (Model 
2100) on the sciatic nerve. 
16. Keep the muscle warm with a radiant heat lamp, and occasionally moisten the muscle 
and nerve with mineral oil. 
17. Using a micrometer, find the muscle’s optimal length. 
18. Stimulate the LGAS at 150Hz to determine peak tetanic tension. Allow two minutes 
of rest between contractions. 
19. After functional analysis is completed, remove the gastrocnemius and other tissues of 
interest. 




21. Weigh muscles and measure the length of the LGAS. 
22. Freeze muscles in liquid nitrogen cooled isopentane and store in -80°C freezer. 
Ⅴ. Hematoxylin & Eosin Staining: 
Hematoxylin & Eosin staining is one of the most widely used stains in histology to 
examine skeletal muscle morphology. Hematoxylin stains nucleic acids a dark blue-
purplish color. Eosin stains cytoplasm and skeletal myofiber a pink color. 
Protocol 
1. Immerse slides in Harris Hematoxylin using Coplin jars for five minutes. 
2. Immerse slides in tap water until water runs clear. 
3. Immerse slides in Eosin for two minutes. 
4. Immerse slides in tap water until water runs clear. 
5. Immerse slides in 70% ethanol for several seconds. Ethanol will dehydrate the section 
and remove excess eosin. 
6. Immerse slides in 100% ethanol for several seconds. 
5. Under the fume hood, immerse slides in Xylene for several seconds. Xylene will make 
the tissue hydrophobic so a coverslip can be applied with a resin in solvent (Permount). 
6. Remove the slides from Xylene and allow slides to dry in the hood. 
7. Apply a coverslip using Permount. 




labeled ‘used’ bottle. 
Ⅵ. Masson’s Trichrome Staining: 
Masson’s trichrome is a three-color staining to distinguish cells from surrounding 
connective tissue. This staining produces darkish red keratin and myofibers, blue 
collagen, light red or pink cytoplasm, and black cell nuclei. It is produced by immersion 
into Bouin’s solution, Weigert’s iron hematoxylin, Beibrich scarlett acid fuchshin, 
phosphotungstic/phosphomolybdic acid, aniline blue and acetic acid. 
Protocol 
1. Immerse slides in 10% Formalin for 1 hour to fix sections.  
2. Re-fix sections in Bouin’s solution overnight. 
3. Pour out solution and gently rinse slides with tap water to remove yellow color from 
sections. Then briefly rinse with dH2O 
4. Incubate sections in working Weigert’s iron hematoxylin for 5 min. 
5. Pour out solution and immerse the slides in water under running tap water to wash 
out excess of Hematoxylin and to intensify the black color of nuclei. Then rinse with 
dH2O for 1 minute 
6.  Incubate sections in Beibrich Scarlett-Acid Fuchshin for 5 min. 
7. Pour out solution and rinse slides in dH2O for 3x 1 minute 




9. Pour out solution and directly immerse sections in Aniline blue for 3 minutes. 
10. Pour out solution. Then briefly rinse with dH2O for 3x 1 minutes. 
11. Icubate sections in 1% acetic acid for 2 minutes. Then briefly rinse with dH2O for 2x 
1 minutes. 
12. . Dehydrate sections sequentially exposing to a series of solutions for 3 minutes: 70% 
ethanol, 90% enthanol, 100% ethanol, and xylenes. 




Primary (1°) Antibodies:  
• Neurofilament 200: identifies the wide neurofilament in both central and peripheral nerves. 
- Sigma,N4142. Stored at -20ºC  
•PECAM-1 : identifies the endothelial cells and platelets 
-BD Pharmingen. Stored at4ºC 
Secondary (2°) Antibodies:  
• Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+L) Antibody 
- Lifetechnologies A-11008. Stored at 4ºC 
 Excitation Wavelengths:  
 Fluorescein: 488 nm; broad spectrum; easily photobleached  
 • Donkey Anti-Mouse IgG H&L (TRITC) preadsorbed 
- Abcam ab7058. Stored at -20ºC 
Absorption Wavelength: 550 nm Emission Wavelength: 570 nm 




Blocking Agents:  
• Bovine Serum Albumin (BSA): is able to stabilize enzymatic reactions and enzyme; also 
prevents adhesion of enzymes from equipment surfaces  
- Fischer Scientific, BP1605-100 Stored at 4ºC  
• Normal Serum (Goat and Donkey): used to inhibit non-specific binding of antibodies during 
immunofluorescent staining procedures 
Protocol  
1. Immerse slides in cold Acetone for 5 minutes. 
2. Immediately, rinse slides with PBS 3 times for 5 minutes. 
3. Immerse slides in 5% normal serum and 1% BSA in PBS for 1 hour at room 
temperature. 
4. Draw circles around specimen using a barrier pen, in order to keep solutions on the 
slide. 
5. Rinse slides with PBS 3 times for 5 minutes. 
6. Incubate tissue slides in PECAM-1 (1:20) or Neurofilament 200 primary antibody 
(1:200) overnight at 4 °C 
7.  Rinse slides with PBS 3 times for 5 minutes. 
8. Incubate sections for 30 minutes in Alexa 488 secondary antibody (1:200) for 1 hour 
at room temperature.. 
9. Rinse with PBS 3 times for 5 minutes. 
10. Incubate sections in Dapi (1:1000) for 15 minutes at room temperature  




APPENDIX B: RAW DATA 
1. Entire Region 



























Def DEF 3 170551 40 177468 40 191363 40 160940 36 209808 47
DEF 3 211896 47 221613 54 216651 59 223959 50 202345 45
DEF 3 194501 44 171685 30 138697 28 189161 33 203772 38
DEF 5 216974 45 197988 36 214307 37 209873 37 195088 34
DEF 5 186397 42 209393 48 208575 45 213838 46 217335 44
DEF 5 236306 52 216637 45 215443 38 199135 46 181266 32
DEF 6 184311 44 199738 42 196443 39 211961 49 228574 49
DEF 6 184437 47 187771 36 184711 44 207729 42 183227 40
DEF 6 218516 48 221082 43 226446 43 225352 41 203307 32
DEF 7 221912 53 218179 49 218817 54 223790 53 208518 47
DEF 7 222501 53 216001 54 231931 56 213472 58 203776 62
DEF 7 227268 57 208516 48 214480 50 208011 51 209380 45
INJ INJ 3 175833 42 195885 51 186261 46 217339 53 199404 43
INJ 3 184885 41 199934 44 149680 38 157533 35 194980 47
INJ 3 208263 42 206024 42 178799 42 180194 35 191509 42
INJ 4 203685 33 194215 33 203367 36 203655 42 197466 39
INJ 4 167903 39 179675 39 205009 42 185890 44 194781 37
INJ 4 201824 45 203732 42 215868 40 200793 34 194911 38
INJ 5 195912 40 193936 39 182252 43 168095 39 199666 42
INJ 5 192974 38 187900 31 194524 38 181285 33 207041 39
INJ 5 221456 42 197812 29 164509 31 175515 35 195537 40
INJ 8 206691 46 181201 43 190757 45 128763 25 160653 51
INJ 8 177053 38 212284 47 166844 41 194835 46 213626 51
INJ 8 195966 38 185522 42 184926 40 196410 41 239924 45
EXE EXE 1 219708 53 201354 43 182713 38 184310 36 213493 34
EXE 1 181534 33 207336 46 222685 47 188923 43 204908 47
EXE 1 223633 44 225883 50 212287 45 192939 48 209264 47
EXE 3 216205 47 209445 41 189859 38 189119 36 196077 40
EXE 3 193106 44 199036 41 201117 43 193356 39 171718 30
EXE 3 171389 30 184108 39 203927 42 204568 40 220844 40
EXE 4 171389 34 184108 31 203927 34 204568 31 220844 30
EXE 4 172718 36 205655 37 185943 32 205029 34 194621 34
EXE 4 220628 44 219944 38 178216 28 200267 40 204903 42
EXE 6 192650 30 202431 39 222598 36 190862 39 198701 37
EXE 6 219248 46 206828 43 185060 40 210472 54 177834 41
EXE 6 200566 33 217613 40 225096 49 202665 49 196400 49
INJ+EXE INJ+EXE 1 202103 45 175779 32 193938 37 196115 38 222129 44
INJ+EXE 1 218933 43 190336 44 225673 50 211927 48 205795 49
INJ+EXE 1 184488 40 184999 41 177990 33 184064 37 206586 37
INJ+EXE 2 181890 34 207880 38 181289 35 213671 41 176892 24
INJ+EXE 2 180783 30 156423 26 209473 49 202064 37 202726 38
INJ+EXE 2 172876 46 185676 36 178640 27 149217 28 148651 36
INJ+EXE 3 192848 45 212445 41 198710 38 185611 35 221271 39
INJ+EXE 3 163095 38 136848 30 199068 42 149538 34 157016 39
INJ+EXE 3 193029 47 165940 42 178785 43 215165 47 205994 41
INJ+EXE 5 194515 46 208857 49 211319 52 190894 48 209755 46
INJ+EXE 5 198332 36 209778 54 120753 33 197134 56 175665 47




Nerve CSA (μm2) and number 
 
INJ 3 INJ 4 INJ 5 INJ+EXE 1 INJ+EXE 2 INJ+EXE 3 DEF 3 DEF 5 DEF 6 EXE 1 EXE  3 EXE 5
59570 1233 2673 461 1281 1079 17361 1575 1282 755 896 4926
4150 1197 1360 56563 287 5959 38207 1622 513 1825 765 2760
1266 430 244 6130 290 17419 2515 125 222 403 711 981
994 2099 214 3719 230 1712 370 345 4056 427 342 20348
1216 863 619 14974 2177 2219 392 243 1134 4095 1442 3656
16522 58556 1399 310 636 5737 638 1808 1494 5539 827 956
1113 5033 270 354 551 846 695 64439 819 16448 619 3659
576 329 387 250 132 2579 701 5386 738 2391 1744 658
47325 312 2144 692 627 1605 3518 12450 14487 763 995 1752
1217 236 5501 352 679 587 320 226 5910 1592 96715 423
2433 105 72158 137 2718 2503 462 545 838 1000 1410 255
873 516 18467 473 27414 421 1127 1744 424 20208 1239 562
788 864 1604 2858 2034 564 1161 1245 278 35033 18618 867
14322 4832 770 913 218 7029 343 792 1632 12427 1390 1465
772 351 11630 164 5552 1865 364 701 1269 22146 4223 1947
1393 24760 559 1376 13983 117138 615 688 2471 8743 1486 234
577 1153 2900 503 2302 8921 53749 519 7255 6463 525 490
104 296 2628 216 615 1539 3978 662 1500 888 494 844
764 621 2484 6320 232 408 14282 289 724 19896 20057 445
254 486 232 61511 1491 556 680 1998 93941 6366 9310 2067
567 1199 343 1204 1889 407 258 260 8321 550 1459 458
289 20980 1024 300 449 244 368 529 11005 8429 1235 357
812 698 518 803 485 5727 853 1642 10597 18375 2599 333
386 37764 1258 516 19259 218 2509 17731 67536 9963 3968 862
2044 201 369 642 6385 395 305 56513 4914 5464 577 790
2668 11767 4535 17048 68254 709 269 1596 3874 500 447 385
2203 356 60061 664 23006 395 727 292 489 11827 962 4291
314 1827 34871 792 10630 21033 697 2293 367 7207 289 1010
417 2158 542 341 313 4189 1122 627 1048 484 371 460
15541 693 565 353 669 372 255 20190 715 1278 780 2298
662 81 3132 637 653 620 510 2989 481 40741 968 13503
907 1241 314 1154 152 1034 12516 680 874 1164 639 3755
495 3930 669 7841 528 463 8225 443 573 1223 466 2386
1743 316 566 1220 1221 272 57506 320 14974 1290 1270 351
67380 25775 830 3128 2276 58776 4166 423 886 860 73521 435
1326 422 1070 46363 3977 1583 943 446 568 12581 496
86401 3284 54129 6619 274 2923 78259 594 4889 1313
3099 5363 7069 2708 466 549 3426 999 4406 198
288 571 691 909 17409 1142 553 362
13658 293 1717 342 51657 715 2298 9474
14562 326 627 5382 19841 731 1813 55320
3902 791 322 609 793 824 21189
458 1480 365 406 595 292 567
730 226 302 2432 926 297 575
1508 274 660 1159 351 631
289 182 191 1125 430 1549
3834 394 373 195 432
935 1451 16937 1645
509 589 4166 513
331 1095 19836 1137
756 312 8232 381



























Def DEF 3 7 43
DEF 3 17 32
DEF 3 14 36
DEF 5 11 13
DEF 5 7 7
DEF 5 12 17
DEF 6 14 16
DEF 6 15 19
DEF 6 22 21
DEF 7 4 12
DEF 7 11 33
DEF 7 7 12
INJ INJ 3 11 20
INJ 3 13 32
INJ 3 5 13
INJ 4 4 24
INJ 4 19 32
INJ 4 15 42
INJ 5 8 26
INJ 5 7 26
INJ 5 11 25
INJ 8 7 20
INJ 8 8 31
INJ 8 9 25
EXE EXE 1 7 35
EXE 1 15 28
EXE 1 13 60
EXE 3 5 14
EXE 3 11 28
EXE 3 14 30
EXE 4 4 27
EXE 4 6 38
EXE 4 17 30
EXE 6 21 45
EXE 6 14 34
EXE 6 17 42
INJ+EXE INJ+EXE 1 8 14
INJ+EXE 1 14 20
INJ+EXE 1 11 31
INJ+EXE 2 5 21
INJ+EXE 2 9 19
INJ+EXE 2 12 28
INJ+EXE 3 7 25
INJ+EXE 3 10 18
INJ+EXE 3 9 24
INJ+EXE 5 11 33
INJ+EXE 5 10 30









Area (mm2)    
ECM FIB EXE FIB+EXE 
0.490  0.974  1.503  1.332  
0.300  0.273  1.076  0.610  
0.689  0.870  1.595  0.421  













ECM FIB EXE FIB+EXE
69 57 48 52
69 69 45 65
74 42 43 74
65 50 _ 64
Nerve
ECM FIB EXE FIB+EXE
15 18 15 13
15 8 14 18

























ECM FIB EXE FIB+EXE
49 45 43 34
14 51 39 28




ECM FIB EXE FIB+EXE
32 32 28 20
7 32 28 19
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